INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Retrophin, Inc. (RTRX) To Contact The Firm

News provided by

Oct 21, 2014, 06:04 ET

NEW YORK, Oct. 21, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Retrophin, Inc. ("Retrophin" or the "Company") (NASDAQ: RTRX) of the December 19, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Retrophin and certain executives.

A complaint has been filed in the United States District Court for the Southern District of New York on behalf of all persons who purchased Retrophin securities between March 27, 2014 and September 30, 2014, inclusive (the "Class Period").

The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

Specifically, the action alleges that during the Class Period, Retrophin made false and/or misleading statements and/or failed to disclose that Retrophin's founder and Chief Executive Officer had made irregular stock trades and committed other violations of the Company's Incentive Compensation Plan (the "Plan") and other securities rules, including granting shares in violation of the Plan and the failure to disclose stock grants to employees.

On September 30, 2014, Retrophin issued a press release announcing that its Board of Directors terminated its Chief Executive Officer.

Following this news, the price of Retrophin stock declined by $0.40 per share, or over 4%, to close on October 1, 2014 at $8.62 per share.

Request more information now by clicking here: www.faruqilaw.com/RTRX. There is no cost or obligation to you.

Take Action

If you invested in Retrophin common stock, bonds or options between March 27, 2014 and September 30, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/RTRX. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Retrophin's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-100000-investing-in-retrophin-inc-rtrx-to-contact-the-firm-328350155.html

SOURCE Faruqi & Faruqi, LLP